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Throughout life, patients with multiple sclerosis (MS) require increasing levels of support, rehabilitative services, and eventual
skilled nursing facility (SNF) care.There are concerns that access to SNF care for MS patients is limited because of perceived higher
costs of their care.This study compares costs of caring for anMS patient versus those of a typical SNF patient. Wemerged SNF cost
report data with the 2001–2006 Nursing HomeMinimumData Set (MDS) to calculate percentage of MS residents-days and facility
case-mix indices (CMIs). We estimated the average facility daily cost using hybrid cost functions, adjusted for facility ownership,
average facility wages, CMI-adjusted number of SNF days, and percentage ofMS residents-days.We describe specific characteristics
of SNF with high and low MS volumes and examine any sources of variation in cost. MS patients were no longer more costly than
typical SNF patients. A greater proportion of MS patients had no significant effect on facility daily costs (𝑃 = 0.26). MS patients
were more likely to receive care in government-owned facilities (OR = 1.904) located in the Western (OR = 2.133) and Midwestern
(OR = 1.3) parts of the USA (𝑃 < 0.05). Cost of SNF care is not a likely explanation for the perceived access barriers thatMS patients
face.
1. Introduction
Multiple sclerosis (MS) affects younger adults and leads to
permanent disability. As a result of MS progression and re-
lapses, manyMS patients require increasing levels of medical
and supportive services and eventually may need long-term
skilled nursing facility (SNF) care.
Since 1999, the United States Supreme Court’s decision
of Olmstead v. L.C., a ruling that requires states to eliminate
unnecessary segregation of persons with disabilities and
to ensure that persons with disabilities receive services in
the most integrated setting appropriate to their needs, has
shifted the landscape of services for individualswith disability
[1]. Earlier reports by MS patient organizations, care-givers
groups, and policy advocates expressed concerns that SNFs
and long-term care insurance plans may perceive cost of care
for an individual withMS higher than the costs of caring for a
typical (elderly and frail) SNF resident, and, hence, they may
selectively encourage MS patients with skilled nursing care
needs to leave their facility or deny admission [2–4]. Research
suggests several potential reasons for this “cream-skimming”
behavior that may lead to difficulties for MS patients getting
the skilled nursing care they need. These factors include
younger age of MS patients compared with other facility
residents that may substantially reduce MS patient satisfac-
tion with care and quality of life, specific symptoms, and
healthcare problems associated with MS (i.e., pain, cognitive
impairment, numbness, spasticity, and fatigue) and types of
services they may require (i.e., rehabilitating and behavioral
or occupational therapy) [5–7].
In this study, we aimed to examine the incremental
costs of care for SNF residents with MS and to answer the
question whether an MS resident in a nursing home imposes
additional costs on the facility, compared with the typical,
or average, nursing home resident. We tested two distinct
hypotheses. First, we examined whether SNFs with a higher
number of MS residents-days are different from SNFs with
fewer MS residents. Second, using a cost function model,
we calculated the incremental costs due to an increase of 1
percent in MS residents-days provided by a facility.
2 Multiple Sclerosis International
2. Methods
2.1. Theoretical Background: Cost Function Estimation. Fol-
lowing the methods used in our previous work [8], we
estimated facility cost functions that explicitly modeled the
relationship between the costs of care provided by the nursing
home, the costs of inputs used to produce the care (e.g.,
wages of nurses aides), and the amount of care provided
(e.g., number of nursing home days). In order to be able to
assess the incremental costs due to caring forMS residents, we
included in the model the percent of MS inpatient days in the
facility. The estimated coefficients from this model allowed
us to calculate the incremental costs (actually, log(costs))
faced by a provider treating an additional 1% of MS patients.
We note that because the model included case-mix-adjusted
days and admissions, the differential cost estimated for MS
patients was the cost above and beyond any cost differences
due to differences in health statuses and demographics (i.e.,
age and gender) between MS and non-MS residents.
We estimated the total cost using a hybrid cost function,
following Grannemann and Brown [9] and Nyman [10] to
allow flexibility in the functional form. We estimated the
model of the following general form:
log𝐶 = 𝜙𝑋 +∑
𝑖
𝑎
𝑖
log𝑊
𝑖
+ 𝛽CMO + 𝛾%MS, (1)
where 𝐶 is the annual total cost of the provider, 𝑋 is a set of
potential variables likely to influence costs (e.g., profit versus
nonprofit ownerships), 𝑊 are the county-year means of
average facility wage, CMO is the case-mix-adjusted measure
of outputs such as the Resource Utilization Groups (RUGs)
score-adjusted nursing home days and admissions [11, 12],
and %MS is the percentage of days provided to MS patients.
Nursing home case-mix indices (CMIs) are used by the CMS
to adjust facility reimbursement based on the severity of
resident illness in each facility in a given time. The CMIs
at admission and annual averages were calculated using the
methodology developed by the CMS [11, 12]. Since there were
multiple records per facility, we adjusted for the correlation
among observations provided by the same facility (see the
appendix for more details).
2.2. Data Sources. This study was based on the analysis of
two databases: the 2001–2006 skilled nursing facility (SNF)
cost reports for all USA Medicare-certified facilities and the
national Minimum Data Set (MDS) data. The SNF Medicare
cost reports are prepared for fiscal purposes by all Medicare-
certified free-standing SNFs and contain information about
facility characteristics, facility wages, cost allocation based
on cost center, and services provided [13]. The Minimum
Data Set (MDS) [6, 14] is a standardized screening and
assessment tool which forms the foundation of the compre-
hensive assessment for all residents (regardless of the source
of payment) of Medicare- and Medicaid-certified nursing
homes. Together, these two data sources provided us with the
necessary information to develop cost function and assess
marginal cost of providing care to SNF residents with MS
compared with costs for residents without MS.
2.3. Analytical Datasets. We merged the SNF cost report
data with the MDS data using facility Medicare numbers
and MDS facility internal IDs (Figure 1). MS residents were
identified based on the MS status indicator reported by the
admitting physician in the MDS dataset. We used the MDS
health status assessment data to calculate percentage of MS
days (i.e., inpatient days of care of MS patients as a fraction
of total facility inpatient days) and facility case-mix indices
(CMIs) [15]. The final dataset without duplicates included
13,656 nursing homes (94% of all SNFs represented in the
2006 cost reports) (Figure 1).
We assumed that, for facilities with very lowproportion of
MS days (<3%), the cost of care for MS patients is unlikely to
have any impact on facility financial stability. Hence, for our
analysis, we identified a subset of SNFs with an adequate vol-
ume (number of MS patients) for financial impact statistical
assessment (facilities with a percentage ofMSdays in a facility
as ≥3%, which is the 90th percentile in the distribution of
SNF mean percentage of MS days, or about 20% of all SNFs)
during at least one year. Forty-four (44) records for 9 facilities
were excluded as outliers: 3 facilities that specialize in care
for MS patients (more than 30% of MS days) and 6 facilities
based on poor MIXED model fit using influence diagnostics
[16]. The final analytical dataset for the cost function model
included 16,707 observations from 3,065 facilities.
2.4. Analysis. To test our hypotheses, we performed the anal-
yses in two stages. First, we examined how facilities that serve
MS patients are different from facilities that serve none or a
few (Tables 1(a) and 1(b)). Then, we focused on the facilities
that serve a substantial number of MS patients (defined as at
least 2.8% of their patients having a diagnosis ofMS). For this
subset of SNFs, we estimated the impact of the percentage
of MS days on facility costs (Table 2) and sought out any
evidence whether facilities with high-percentage MS patients
may be a substantively different class of SNFs (Table 3).
2.4.1. Characterizing Facilities by Proportion of Admitted MS
Patients. We developed a logistic model to compare facilities
that consistently admit a greater number of MS patients
(higher MS patient volume) with facilities that only treat a
few or no MS patients. The binary dependent variable was
whether this facility has a high MS volume (results reported
in Table 1(b) are for facilities with more than 3% of MS
inpatient days). Independent variables included the following
predictors characterizing SNFs: US region of SNF location,
type of facility (not for profit, for profit, or governmental),
facility mean cost per day, annual number of inpatient days
and admissions, and facility average case-mix index. The
facilitymean cost per daywas adjusted for case-mix, inflation,
and geographical variation in medical care prices (CMS 2010
Wage Index for skilled nursing facilities). This facility-level
analysis was performed on 13,656 SNFs.
We repeated the logistic and mixed regression model
analyses while varying our definition of “high MS patient
volume” facility (using 1%, 1.5%, 2%,. . ., 6% thresholds). The
findings were consistent for all threshold values, and, hence,
only results with 3% cutoff are presented in Table 1(b).
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Number of records in the 
original SNF cost file
83,511
No duplicates for 
provider/years
14,507 SNFs
Records/obs with non-
missing essential variables
71,780
Matched with MDS
Remove ob w/nonmatching 
values 
70,922 obs
13,682 SNFs
SNFs w/max %MS   
SNFs w/max %MS days 
SNFs w/max %MS  
79,586 (100%) obs
71,699 (90%) obs
Remove cost-per-day
outliers
70,807 (89%) obs
13,656 (94%) SNFs
10,582 (73%) SNFs
16,752 (24%) obs
3,074 (21%) SNFs
3,065 (21%)
model
16,707 (20%)
13,778 (95%) SNFs
days days
54,055 (65%) obs
≥3% <3%
<30%
Figure 1: Medicare cost reports: flowchart.The hybrid cost function
was estimated on a subset of SNFs including about 20% of facilities
with more than 3% of annual residents-days attributed to patients
with MS. The dependent variable was defined as logarithmic trans-
formation of skilled nursing facility inpatient costs. The independent
variables included facility percent of MS days, county-year mean
of facility average wage, number of inpatient days and admissions,
facility for-profit and ownership status, area competition index, and
interactions between them. MS = multiple sclerosis; SNF = skilled
nursing facility.
2.4.2. Estimating Average Facility Daily Costs Using Cost Func-
tion. For the subset of SNFs with a percentage of MS days in
a facility as ≥3%, we developed a cost function to estimate
average facility costs. The dependent variable was defined
Table 1: Characteristics of SNF facilities with high versus low MS
volumes.
(a)
SNF characteristics
Facility MS volume
𝑃Low (<3%) High (>3%)
Number (%) Number (%)
All 12,508 (92%) 1,148 (8%)
Region
<0.0001
Northeast 2,385 (19%) 208 (18%)
Midwest 3,695 (30%) 465 (41%)
South 4,679 (37%) 146 (13%)
West 1,749 (14%) 329 (28%)
Type of ownership
<0.0001For profit 9,564 (76%) 840 (73%)
Not for profit 2,546 (20%) 229 (20%)
Governmental 398 (4%) 79 (7%)
(b)
Mean (std. dev.) Mean (std. dev.) 𝑃
Cost per day 217 (107) 213 (89) 0.110
Inpatient days 36,556 (21) 33,204 (21) <0.0001
Admissions 239 (218) 197 (162) <0.0001
Case-mix index 0.939 (0.10) 0.926 (0.08) <0.0001
MS: multiple sclerosis; SNF: skilled nursing facility; 𝑃: 𝑃 value; std.
dev.: standard deviation.
MS volume is defined as the annual percentage of patients-days
attributed to multiple sclerosis.
as the logarithmic transformation of skilled nursing facility
inpatient costs.To calculate inpatient costs, we used inpatient-
to-total revenue ratio from the SNF cost report.
The unit of analysis for the cost function model is
facility-fiscal year, with maximum of six records (i.e., years
of data) per facility. The independent variables included
facility percentage of MS days (average by facility and by
facility-year), county-year mean of facility average wage, and
number of inpatient days and admissions, as well as the
facility for-profit and ownership status, the area competition
index, and the interactions between them. The logarithmic
transformationswere also used for the following independent
variables in the model: total number of inpatient days, total
number of admissions, and wages.The wages were calculated
as year-specific county means of average nursing home staff
wages [13]. For the counties in rural areas that had only one
facility per county, we used state/rural/year averages instead.
Number of inpatient days was adjusted for severity of facility
population illness using facility CMI [11]. We also included
competition variable (1-HHI), where HHI is the Herfindahl-
Hirschman index [17, 18], and type of facility ownership (i.e.,
government owned, not for profit, or for profit).
We inflated costs and wages to 2006 level, the last year
of the dataset, using the Medical Care component of the
Consumer Price Index [19]. Since the reported periods were
defined as facility-fiscal year which varied by nursing homes,
we calculated separate inflation factors for each time period.
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Table 2: Multivariate analysis: facility odds of having high MS volume (defined by pct MS days > 3%).
Effect OR 95%Wald confidence limits 𝑃 value
Region
Midwest versus Northeast 1.300 1.084 1.559 0.005
South versus Northeast 0.338 0.270 0.422 <.0001
West versus Northeast 2.133 1.750 2.600 <.0001
Type of ownership
“Not for profit” versus “for profit” 0.909 0.770 1.072 0.255
Governmental versus “for profit” 1.904 1.452 2.497 <.0001
Mean cost per day, $100 s 0.994 0.931 1.062 0.857
Mean𝑁 of inpatient days, 100Ks 0.887 0.586 1.343 0.571
Mean𝑁 of admissions, 10 s 0.988 0.983 0.993 <.0001
Mean case-mix index (CMI) 0.924 0.448 1.904 0.831
OR = odds ratio; c-statistic = 0.776.
Table 3: Factors contributing to variation in MS days among facilities with high MS volume.
Number of SNFs 1,148
Number of observations 5,947
Effect Estimate Standard error 𝑃 value
Intercept 5.522 0.669 <.0001
Region
Midwest versus Northeast −0.014 0.165 0.933
South versus Northeast −0.298 0.159 0.061
West versus Northeast 0.361 0.179 0.044
Type of ownership
“Not for profit” versus “for profit” −0.009 0.089 0.924
Governmental versus “for profit” 0.030 0.222 0.893
Mean cost per day, in $100 0.118 0.069 0.088
Mean𝑁 of inpatient days, 100K 0.471 0.373 0.207
Mean𝑁 of admissions, in tens −0.007 0.005 0.158
Mean case-mix index (CMI) −1.733 0.678 0.011
SNF: skilled nursing facility; see the appendix for performance of the mixed model.
In this model, we controlled for facility effect by using
facility-level random effects and by specifying the covariance
of residuals as autoregressive order 1 (AR1) (the appendix).
3. Results
3.1. Facility Characteristics and Subgroups. On average, 1.2%
of annual facility days were attributed to MS patients. We
found that facilities that provided care to a larger percentage
of MS patients were much more likely to be located in the
West (28% versus 14%, 𝑃 < 0.001) and the Midwest (41%
versus 30%) of the country and much less likely to be in
the South (13% versus 37%, Table 1). Facilities with high
percentage of MS patients also had fewer admissions, even
after controlling for the number of care days (potentially,
indicating lower patient turn-around and more custodial or
permanent stays) (OR = 0.988; 𝑃 < 0.001) and were more
likely to be government-owned (OR = 1.904; 𝑃 < 0.001)
(Table 2). Of note, facilities with high percentage of MS
patients, above 35, did not have a higher average case-mix
index nor did they have higher costs per day (Table 2).
We also examined factors that explain variation in the
percentage of MS-specific care days for those SNFs that care
for a substantial number of MS residents—in the top 20th
percentile of the distribution—that is, with ameanpercentage
of MS days as >3% (see Table 3). Besides some regional
variation, the only other statistically significant difference
was that lower facility mean CMI was associated with higher
percentage of MS days (coefficient −1.733, 𝑃 = 0.011)
(Table 3).This translates into a 0.27 difference inmean facility
CMI (equal to the difference between the 95th and 5th
percentiles) being equivalent to 0.5% decrease in the facility
percentage of MS care days.
3.2. Impact of Percentage of MS Patients in Facility on Facility
Costs. Table 4 presents the estimated cost function. The
estimates show the expected behavior of a cost function
with costs increasing with admissions, days, case mixes, and
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Table 4: Effect of MS volume on SNF inpatient costs (Model 1).
Parameters Estimate RSE 𝑃 value
Intercept 2.747 0.119 <.0001
Facility percent of MS days −0.001 0.001 0.26
Facility mean %MS days 0.002 0.003 0.435
Log of wage 0.143 0.026 <.0001
Log of total case-mix-adjusted inpatient days 0.643 0.019 <.0001
Log of N of admissions adjusted for case mix 0.030 0.003 <.0001
Facility mean of log of wages 0.997 0.045 <.0001
Facility mean of log of total inpatient days 0.288 0.024 <.0001
Facility mean of log of total𝑁 of admissions −0.007 0.008 0.367
Competition −0.010 0.019 0.609
Not for profit 0.033 0.021 0.105
Governmental 0.119 0.038 0.002
Interaction of competition and NFP 0.044 0.032 0.168
Interaction of competition and governmental 0.029 0.057 0.613
RSE: robust standard error; MS: multiple sclerosis.
Log of total case-mix-adjusted inpatient days.
Facility wage is the county/year mean of average SNF wages. Wages were adjusted for inflation.
NFP: not for profit.
Using facilities’ REs and AR (1) structure of residuals errors.
See the appendix for performance of the mixed model.
wages. However, after controlling for facility characteristics,
we found no significant effect of the percentage of MS days
on the facility inpatient costs (𝑃 = 0.26) suggesting that MS
patients do not impose higher costs above and beyond those
due to their disability as captured by their RUGs score, as they
are captured for all other SNF residents. Factors associated
with higher facility inpatient costs included higher local
wages (0.143, 𝑃 < 0.001), greater number of admissions and
inpatient days (0.030 for admissions and 0.643 for inpatient
days, 𝑃 < 0.001), and government ownership (0.119, 𝑃 =
0.002).
4. Discussion
We investigated whether the reason why MS patients may
be facing barriers to SNF care access because their care
may be more costly than what facilities spend on other SNF
residents. We found no significant association between the
percentage of MS residents-days in an SNF in a given year
and facility inpatient costs. We also found that government-
owned SNFs weremore likely to care forMS patients and that
such facilities tended to have higher daily costs.
This finding could have several interpretations. First,
government-owned facility may be less likely to discriminate
against patients with unique needs and those who could
potentially be a high burden on staff, like patients with MS.
Second, these high-cost facilities are likely to have greater
staff-to-residents ratio and may be able to provide more
specialized services which patients with MS require and seek
(e.g., mental health and psychological counseling; physical,
occupational, and speech rehabilitation; and therapy [20]).
As a result, larger facilities may attract and admit more
MS patients. Finally, public/government-sponsored facilities
may serve a greater proportion of Medicaid-eligible residents
including MS patients who often become eligible for Medi-
caid because of disability-related unemployment, long history
of high medical bills, and, subsequently, poverty.
Our results also demonstrated that facilities with higher
percentage of MS residents had lower resident turn-around
and, actually, had lower CMI (average patient severity of
illness). This is consistent with prior findings that MS res-
idents are more likely to have permanent (custodial) SNF
stays rather than transient stays, for rehabilitation or care-
giver respite [21]. Earlier studies also have indicated that MS
patients with both functional and cognitive impairment were
more likely to have a permanent nursing home admission [2].
We also note that, on average, the percentage of MS
patients among SNF residents (1.2%) was higher than that
of MS prevalence among general population (0.1%) of the
same age [22]. This supports earlier reports [2–4] that MS
patients may have greater long-term and institutional care
needs compared with general population. Our findings that
SNFs in the South tended to have fewer residents with MS
are consistent with the epidemiology of MS and the fact that
MS prevalence is higher in the Northern regions compared
with the Southern parts of the USA.
The fact that our study did not demonstrate an association
between MS and SNF costs may have several explanations.
Using the data from a national survey of informal care-
givers, Buchanan et al. (2010) [2] demonstrated that, in MS
patients, age, bowel dysfunction, poorer health, functional
decline, and caregiver burden were associated with increased
probability of SNF admission. This is different from the
general population where the need for long-term SNF care
is often determined by patient cognitive status. MS patients
are younger and have higher education and better cognitive
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status [23] but worse functional status than a typical SNF
resident. Current RUG-III systems includemultiple qualifiers
thatmay help bettermatch level of a resident’s needwith facil-
ity reimbursement including ADL scores, special care (MS,
tube feeding, and pressure ulcers), and impaired cognition
among others. It is conceivable that the protective effect of
age and education (positive predictors for cognition) and the
negative effect of functional deficiencies (negative predictor
of cognitive decline) cancel each other in terms of SNF costs.
Bowblis (2012) [24] also suggested that patients with long-
term care needs and higher socioeconomic statuses may
choose to reside in assisted-care facilities instead of SNFs.
Similarly, Buchanan (2006) reported that the use of physical
and occupational therapies by residents withMS at admission
to the nursing facility was significantly associated with
payment source, controlling for other independent variables
[25].They concluded thatwhen reimbursementwas available,
these therapies were more likely to be prescribed suggesting
that type of health insurance coverage would be associated
with patient SNF expenses. Finally, MS patients with greater
resources and informal support may be benefiting from
nursing home transitions programs that became available
since the late 1990s [26].
Because of the nature and timeframe of the administrative
data used in this study, our analysis may have several limita-
tions. First, the costs data were aggregated at the facility level,
and, hence, we could only make indirect inferences about
individual patient costs [27].We could not assess whether the
patients with MS who received SNF care were representative
of the entire population of MS patients with SNF needs, nor
could we confirm that MS patients who did receive SNF
care were selectively admitted to SNF because their perceived
needs (at the time of admission)were comparablewith facility
resources. Another limitation of the analysis presented here
is the lack of information about quality of care MS patients
receive in these facilities. It is conceivable that in order to
keep the costs similar for patients with special healthcare
needs (like residents with MS) and other SNF residents, SNF
administrators limit either quantity or selection of services
necessary for patients withMS [25]. Furthermore, behavioral
and cognitive problems are common among long-term care
residents and may substantially influence cost of their care
[6]. However, this study did not take into account the absence
ofmental or behavioral health diagnoses or symptoms among
facility residents with or without MS. Finally, one may
speculate that since resource utilization groups- (RUGs-)
based case-mix measurement system [12] was introduced to
calculate nursing home reimbursement while adjusting for
the resident’s severity of illness and resource use, facilities
no longer have financial disincentive for selectively avoiding
patients with heavier or unique care needs, such as MS
patients. Results of the CMS-funded Staff Time and Resource
Intensity Verification (STRIVE) Projects provide SNF staff
time use data that could help researchers examine the quality
of nursing home care, including residents with and without
MS [13, 28].
In summary, we found that providing SNF care for a
greater proportion of MS patients has no significant effect
on facility costs. There is some evidence indicating that MS
patients are more likely to reside in larger, government-
owned facilities, which are also more likely to serveMedicaid
population and provide a greater variety of services that MS
patients need and seek out. More research is needed to
understand the needs and attitudes towards institutional
care among community-dwelling individuals with MS and
to identify optimal strategies for providing high-quality and
cost-effective skilled nursing care to MS population. In
addition to costs, future studies should examine quality of
care and health outcomes in this population of MS patients.
5. Summary
The study examined whether the costs of caring for young
disabled adults with multiple sclerosis exceed those for a
typical elderly skilled nursing facility patient.
Multiple sclerosis (MS) affects younger adults and leads
to permanent disability. The study examined whether the
institutional costs of caring for young disabled adults with
multiple sclerosis exceed the cost of care for a typical elderly
skilled nursing facility patient, and we found the following.
(i) MS patients were no more costly than typical patients
in skilled nursing facilities.
(ii) MS patients tend to cluster in larger government-
owned facilities located in the West and the Midwest
of the USA.
It is unclear, however, how the efforts tomaintain same-for-all
cost of caremay impact the quality of services forMSpatients.
Appendix
Controlling for the Correlation among
Multiple Observations Provided by the
Same Facility
Since there were multiple records per facility, we adjusted for
correlation among the observations in each facility (within
facility variation). To insure robustness of our estimation
strategy, we estimated four distinct models.
In the firstmodel (M1), we explicitly controlled for facility
effect by including fixed effects so that the effects of the
variables can be interpreted as “within” facility effects while
facility characteristics are accounted for. We modified this
M1 model by replacing fixed with random facility effects
(Res) (M2) and included facility-level means of the facility
characteristics (i.e., 𝑋, 𝑊, CMO, and %MS) so that the
effect of these variables is still “within” facility effect, net
of facility characteristics. The rest of facility characteristics
were controlled by facility simple REs. Next, we improved the
model by specifying the covariance of residual (in addition to
REs) error terms as autoregressive order 1, to model temporal
correlation (M3). In the final model (M4), we added facility
characteristics such as competition and type of ownership.
In models M2–M4, we used robust (empirical) standard
errors to account for possible departures from the chosen
covariance structure.
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